Evidence map›Paper›PMID 29535868›Full record

ArticleInternational journal of hypertension2018

Factors Associated with Outcomes of Percutaneous Transluminal Renal Angioplasty in Patients with Renal Artery Stenosis: A Retrospective Analysis of 50 Consecutive Cases.

Tetsutaro Matayoshi, Kei Kamide, Ryoichi Tanaka, Tetsuya Fukuda, Takeshi Horio, Yoshio Iwashima, Fumiki Yoshihara, Satoko Nakamura, Hajime Nakahama, Yusuke Ohya and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of hypertension, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment?Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tetsutaro MatayoshiDivision of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, Osaka, Japan.ORCID 0000-0002-3834-4269
Kei KamideDivision of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, Osaka, Japan.
Ryoichi TanakaDepartment of Radiology, National Cardiovascular Center, Osaka, Japan.
Tetsuya FukudaDepartment of Radiology, National Cardiovascular Center, Osaka, Japan.
Takeshi HorioDivision of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, Osaka, Japan.
Yoshio IwashimaDivision of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, Osaka, Japan.ORCID 0000-0002-5661-1105
Fumiki YoshiharaDivision of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, Osaka, Japan.
Satoko NakamuraDivision of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, Osaka, Japan.
Hajime NakahamaDivision of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, Osaka, Japan.
Yusuke OhyaDepartment of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus, Okinawa, Japan.
Yuhei KawanoDivision of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe results of recent trials have brought some confusion to the treatment strategy for renal artery stenosis (RAS). To evaluate the applicability of percutaneous transluminal renal angioplasty (PTRA) for RAS, we extracted the factors that may affect the effectiveness of PTRA from cases experienced at a hypertension center. METHODS AND

resultsWe retrospectively assessed the blood pressure (BP) lowering effects and renoprotective effects in 50 consecutive patients that had hemodynamically significant RAS and had undergone PTRA and stenting during 2001-2005. Subjects were diagnosed with atherosclerotic RAS (42), fibromuscular dysplasia (6), or Takayasu disease (2). After PTRA, BP significantly lowered from 152.3/80.3 mmHg to 132.6/73.2 mmHg (

conclusionIn cases with hemodynamically significant RAS, PTRA lowered BP but was not effective in improving renal function. Higher baseline RI may be a factor for predicting poor clinical course of renal function after PTRA.

Identifiers

PMID29535868
PMCPMC5817381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.